Goblet cells and intestinal immune response in alcohol-associated liver disease
酒精相关性肝病中的杯状细胞和肠道免疫反应
基本信息
- 批准号:10446819
- 负责人:
- 金额:$ 45.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-10 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccountingAcetylcholineAdaptive Immune SystemAddressAgonistAlcohol abuseAlcohol consumptionAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsAntigen PresentationAntigen-Presenting CellsAntigensBacteriaBacterial InfectionsBacterial TranslocationCell CountCell physiologyCellsCellular biologyCessation of lifeChronicCirrhosisColonComplexDataDendritic CellsDietDown-RegulationEnergy-Generating ResourcesEpithelial CellsEquilibriumEthanolExposure toFibrosisFlow CytometryFunctional disorderGenerationsGenesGoalsGoblet CellsHealthcareHumanIL6ST geneImmuneImmune responseImmune systemImmunityIn VitroInflammationInterleukin-6InterventionIntestinal permeabilityIntestinesLamina PropriaLiverLiver diseasesMediatingMessenger RNAModelingMonitorMucin-2 Staining MethodMucinsMucosal Immune SystemMucous body substanceMusMuscarinic Acetylcholine ReceptorMyelogenousNaturePatientsPharmacologyPlayPre-Clinical ModelPredispositionPreventionPreventive therapyProductionPropertyRegulationResearchResistanceRisk FactorsRoleShapesSignal PathwaySignal TransductionSmall Intestinal Goblet CellSteatohepatitisSystemic infectionTechnologyTherapeuticTherapeutic InterventionTimeTransducersUnited StatesVirus DiseasesWild Type MouseWomanadaptive immune responsealcohol exposurealcohol preventionalcohol use disorderbasechronic alcohol ingestionchronic liver diseasechronic liver inflammationcostdesigndysbiosisfeedinggain of functiongut dysbiosisgut microbiotagut-liver axisimmunoregulationimprintin vivoinhibitorinnovationintestinal epitheliumintestinal homeostasismenmicrobialmicrobiome researchmicroorganism antigenpathogenpopulation healthpositive allosteric modulatorpreventresponsesystemic inflammatory response
项目摘要
Project Summary/Abstract
Excessive alcohol drinking modulates the innate and adaptive immune systems. It is associated with gut
dysbiosis and bacterial overgrowth. Consequently, it induces intestinal permeability and microbial translocation
to the liver which triggers inflammation aggravating alcohol-associated liver disease. The immune system
interacts, tolerates, and shapes the intestinal microbiota while monitoring for pathogens. The balance between
gut tolerance and immunity is critical in the regulation of intestinal homeostasis. A balanced intestinal
homeostasis is essential to prevent intestinal permeability and microbial translocation to the liver. Goblet cells
regulate the intestinal immune response by secreting mucin and presenting luminal antigens to lamina propria
dendritic cells (LP-DCs) through goblet-cell associated antigen passages (GAPs). LP-DCs adjacent to GAPs
have preferential tolerogenic properties. Chronic alcohol overuse decreases the pool of myeloid DCs and
modifies its properties. However, the effect of chronic ethanol overuse on the LP-immune response is not well
characterized.
The hypothesis is that chronic ethanol exposure alters goblet cell biology resulting in the dysfunction of
LP-DCs with tolerogenic properties adjacent to GAPs. Hence, a lack of antigen presentation to
tolerogenic LP-DCs would induce an imbalance of the intestinal homeostasis. Therefore, goblet cells
might have a central role in the onset of alcohol-related liver diseases.
To explore the proposed hypothesis, aim 1 will investigate the impact of chronic alcohol abuse on goblet cell
biology. It will assess goblet cell numbers, GAP formation, mucin secretion, and the consequent alterations in
the LP-immune system in mice and humans. Aim 2 will define the impact of GAPs and mucin from goblet cells
on ethanol-induced liver disease in ethanol-fed mice with both, loss and gain of function approaches. Finally,
aim 3 will explore a pharmacological approach to manipulate goblet cells to prevent ethanol-induced liver
disease in mice subjected to chronic ethanol feeding. This pharmacological intervention will induce LP-DCs
with tolerogenic properties by stimulating GAP formation to regulate the mucosal immune system.
The proposed study will characterize the role of goblet cells in preclinical models of ethanol-induced liver
disease and patients with alcohol use disorder using cutting edge microbiomics and state-of-the-art
technology. The proposed intervention will find innovative strategies to prevent alcohol-associated liver disease
in patients.
项目概要/摘要
过量饮酒会调节先天性和适应性免疫系统。和肠道有关系
生态失调和细菌过度生长。因此,它诱导肠道通透性和微生物易位
刺激肝脏,引发炎症,加重酒精相关的肝病。免疫系统
在监测病原体的同时,与肠道微生物群相互作用、耐受并塑造肠道微生物群。之间的平衡
肠道耐受性和免疫对于肠道稳态的调节至关重要。平衡的肠道
体内平衡对于防止肠道通透性和微生物易位至肝脏至关重要。杯状细胞
通过分泌粘蛋白并向固有层呈递管腔抗原来调节肠道免疫反应
树突状细胞(LP-DC)通过杯状细胞相关抗原通道(GAP)。与 GAP 相邻的 LP-DC
具有优先耐受性。慢性酒精过度使用会减少骨髓树突状细胞的数量
修改其属性。然而,长期过量使用乙醇对 LP 免疫反应的影响并不明显
特点。
该假设是,长期接触乙醇会改变杯状细胞的生物学特性,导致杯状细胞功能障碍
LP-DC 具有与 GAP 相邻的耐受性。因此,缺乏抗原呈递
耐受性 LP-DC 会导致肠道稳态失衡。因此,杯状细胞
可能在酒精相关肝病的发生中起核心作用。
为了探索所提出的假设,目标 1 将研究长期酗酒对杯状细胞的影响
生物学。它将评估杯状细胞数量、GAP 形成、粘蛋白分泌以及随后的变化
小鼠和人类的 LP 免疫系统。目标 2 将定义杯状细胞的 GAP 和粘蛋白的影响
通过功能丧失和获得两种方法来治疗乙醇喂养的小鼠中乙醇引起的肝病。最后,
目标 3 将探索一种操纵杯状细胞预防乙醇诱导性肝病的药理学方法
长期喂食乙醇的小鼠患上这种疾病。这种药物干预将诱导 LP-DC
通过刺激 GAP 形成来调节粘膜免疫系统,从而具有耐受性。
拟议的研究将描述杯状细胞在乙醇诱导的肝脏临床前模型中的作用
使用最先进的微生物组学和最先进的技术来研究疾病和酒精使用障碍患者
技术。拟议的干预措施将找到预防酒精相关性肝病的创新策略
在患者中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ana Cristina Llorente Izquierdo其他文献
Ana Cristina Llorente Izquierdo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ana Cristina Llorente Izquierdo', 18)}}的其他基金
The role of intestinal gp130 in alcohol-associated liver disease
肠道 gp130 在酒精相关性肝病中的作用
- 批准号:
10742561 - 财政年份:2023
- 资助金额:
$ 45.87万 - 项目类别:
Goblet cells and intestinal immune response in alcohol-associated liver disease
酒精相关性肝病中的杯状细胞和肠道免疫反应
- 批准号:
10681329 - 财政年份:2022
- 资助金额:
$ 45.87万 - 项目类别:
相似海外基金
Spatiotemporal dynamics of acetylcholine activity in adaptive behaviors and response patterns
适应性行为和反应模式中乙酰胆碱活性的时空动态
- 批准号:
24K10485 - 财政年份:2024
- 资助金额:
$ 45.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural studies into human muscle nicotinic acetylcholine receptors
人体肌肉烟碱乙酰胆碱受体的结构研究
- 批准号:
MR/Y012623/1 - 财政年份:2024
- 资助金额:
$ 45.87万 - 项目类别:
Research Grant
CRCNS: Acetylcholine and state-dependent neural network reorganization
CRCNS:乙酰胆碱和状态依赖的神经网络重组
- 批准号:
10830050 - 财政年份:2023
- 资助金额:
$ 45.87万 - 项目类别:
Study on biological significance of acetylcholine and the content in food resources
乙酰胆碱的生物学意义及其在食物资源中的含量研究
- 批准号:
23K05090 - 财政年份:2023
- 资助金额:
$ 45.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
alpha7 nicotinic acetylcholine receptor allosteric modulation and native structure
α7烟碱乙酰胆碱受体变构调节和天然结构
- 批准号:
10678472 - 财政年份:2023
- 资助金额:
$ 45.87万 - 项目类别:
Diurnal Variation in Acetylcholine Modulation of Dopamine Dynamics Following Chronic Cocaine Intake
慢性可卡因摄入后乙酰胆碱对多巴胺动力学调节的昼夜变化
- 批准号:
10679573 - 财政年份:2023
- 资助金额:
$ 45.87万 - 项目类别:
Striatal Regulation of Cortical Acetylcholine Release
纹状体对皮质乙酰胆碱释放的调节
- 批准号:
10549320 - 财政年份:2022
- 资助金额:
$ 45.87万 - 项目类别:
Differential Nicotinic Acetylcholine Receptor Modulation of Striatal Dopamine Release as a Mechanism Underlying Individual Differences in Drug Acquisition Rates
纹状体多巴胺释放的烟碱乙酰胆碱受体差异调节是药物获取率个体差异的机制
- 批准号:
10553611 - 财政年份:2022
- 资助金额:
$ 45.87万 - 项目类别:
Mechanisms of nicotinic acetylcholine receptor modulation of cocaine reward
烟碱乙酰胆碱受体调节可卡因奖赏的机制
- 批准号:
10672207 - 财政年份:2022
- 资助金额:
$ 45.87万 - 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
- 批准号:
10848770 - 财政年份:2022
- 资助金额:
$ 45.87万 - 项目类别:














{{item.name}}会员




